CODX Change To Account Receivables from 2010 to 2024

CODX Stock  USD 0.81  0.03  3.56%   
Co Diagnostics Change To Account Receivables yearly trend continues to be fairly stable with very little volatility. Change To Account Receivables is likely to outpace its year average in 2024. During the period from 2010 to 2024, Co Diagnostics Change To Account Receivables regression line of annual values had r-squared of  0.01 and arithmetic mean of (165,162). View All Fundamentals
 
Change To Account Receivables  
First Reported
2015-12-31
Previous Quarter
-90.3 K
Current Value
324.1 K
Quarterly Volatility
3.4 M
 
Yuan Drop
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Change To Account Receivables Growth Pattern

Below is the plot of the Change To Account Receivables of Co Diagnostics over the last few years. It is Co Diagnostics' Change To Account Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Change To Account Receivables10 Years Trend
Very volatile
   Change To Account Receivables   
       Timeline  

CODX Change To Account Receivables Regression Statistics

Arithmetic Mean(165,162)
Geometric Mean158,723
Coefficient Of Variation(3,552)
Mean Deviation2,921,396
Median(13,420)
Standard Deviation5,866,753
Sample Variance34.4T
Range27.9M
R-Value0.1
Mean Square Error36.7T
R-Squared0.01
Significance0.74
Slope124,669
Total Sum of Squares481.9T

CODX Change To Account Receivables History

20242.7 M
20232.5 M
202215 M
2021-8.7 M
2020-13 M
2019-121.5 K

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Change To Account Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Account Receivables2.5 M2.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.